Anteris Technologies Global Corp. (AVR) vs Avalo Therapeutics, Inc. (AVTX)
A side-by-side comparison of Anteris Technologies Global Corp. and Avalo Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVR
Anteris Technologies Global Corp.
$7.10HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT
AVTX
Avalo Therapeutics, Inc.
$13.75HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT
Total return — AVR vs AVTX
growth of $100 · dividends reinvested · last 2yAVR +34.8% (+16.1%/yr)AVTX +58.2% (+25.8%/yr)AVTX compounded faster over this window
AVR AVTX
AVR vs AVTX: by the numbers
- •AVTX is the larger company ($723M vs $690M market cap).
- •Both run net losses; AVR's is the smaller (-4619.67% vs -170055.93% net margin).
- •Both shrank revenue over the past five years; AVR's decline was smaller (-18.92% vs -60.88% CAGR).
Metrics side by side
Valuation
| Metric | AVR | AVTX |
|---|---|---|
| P/S ratio | 307.92 | 12250.46 |
| P/B ratio | 2.75 | 1.61 |
Profitability
| Metric | AVR | AVTX |
|---|---|---|
| Gross margin | -16.57% | 100.00% |
| Operating margin | -4908.21% | -123601.69% |
| Net margin | -4619.67% | -170055.93% |
| ROE | -41.20% | -22.36% |
| ROIC | -41.63% | -19.45% |
Growth (annualized)
| Metric | AVR | AVTX |
|---|---|---|
| Revenue CAGR (5Y) | -18.92% | -60.88% |
| Total return CAGR (5Y) | N/A | -70.04% |
Frequently asked
- Which has grown faster, AVR or AVTX?
- Neither grew: over the past five years both shrank revenue, with AVR's decline the smaller — AVR at a -18.92% CAGR versus AVTX at -60.88%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.